NPCE

NeuroPace Inc

Healthcare · Medical Devices

$165.23 sample

-2.56 (-1.53%) 1D

Market cap

$875.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-01

Alerts

8

Price$165.23 -10.60% 3M daily closessample

184.82165.23

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: General Counsel
Sep 22INSInsider sell: 10% owner
Sep 16INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: 10% owner
Sep 01SEC8-K filed: material event
Aug 27INSInsider buy: 10% owner
Aug 19INSInsider sell: Director
Aug 10SEC10-Q filed

Sign up to see the real NPCE record →

Company facts

SEC EDGAR registration

Name: NeuroPace Inc
Sector: Healthcare
Industry: Medical Devices
Smart-money score: +14sample, -100 to +100
Reporting currency: USD

Who is positioning in NPCE

sample

Insiders: 7 insider transactions over 90 days, net selling, $528.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 20 funds hold $19.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$45.7B +15.7% y/y

Q4 2024Q3 2026

Inventory$29.1B +18.9% y/y

Q4 2024Q3 2026

Accounts receivable$21.8B +19.3% y/y

Q4 2024Q3 2026

Total debt$56.0B +7.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $241.1B -11.8% 3M
Sample peer B: $854.5B +13.3% 3M
Sample peer C: $798.4B +12.8% 3M
Sample peer D: $242.4B -11.4% 3M
Sample peer E: $521.4B -8.9% 3M